Example: Heart Attack

Clinical Trials on Arbovirus Infections

Total 411 results

    • NCT03553277
      Completed
      Spatial Repellents for Arbovirus Control
      Conditions: Arbovirus Infections
    • NCT03552094
      Recruiting
      World Mosquito Program Noumea - Human Sample Component
      Conditions: Arbovirus Infections
    • NCT03210363
      Completed
      Sero-epidemiology of Priority Arboviruses in French Guiana
      Conditions: Arbovirus Infections
    • NCT04619823
      Recruiting
      Virological and Immunological Determinants of Arbovirus Infection in New Caledonia
      Conditions: Arbovirus Infections; Zika; Dengue; Chikungunya
    • NCT01868399
      Completed
      Pilot Survey of Dengue Fever in Solomon Islands
      Conditions: Arbovirus Infections
    • NCT00116766
      Completed
      Field Evaluation of Plant-based Mosquito Control
      Conditions: Malaria; Arbovirus Infections
    • NCT02794181
      Completed
      Zika Virus and Related Arbovirus Infections in Deferred Blood Donors (ZVADD)
      Conditions: Zika Virus; Dengue Virus; Chikungunya Virus Infections
    • NCT04615364
      Recruiting
      Genetic Evolution of Arboviruses in New Caledonia Between 1995 and 2024 and Impact of Wolbachia
      Conditions: Arbovirus Infections; Dengue; Zika; Chikungunya
    • NCT03206541
      Completed
      Neurologic Manifestations of the Arbovirus Infection in Colombia
      Conditions: Encephalitis; Myelitis; Guillain-Barre Syndrome; Cranial Nerve Palsies; Meningitis; Zika Virus Infection; Dengue (Virus); Fever, Sandfly; Chikungunya Fever
    • NCT03631719
      Unknown status
      Impact of Wolbachia Deployment on Arboviral Disease Incidence in Medellin and Bello, Colombia
      Conditions: Dengue; Chikungunya Virus Infection; Zika Virus Infection
    • NCT01099852
      Recruiting
      Cohort of Patients Infected by an Arbovirus
      Conditions: Fever; Dengue; Chikungunya; Zika Virus
    • NCT03776994
      Active, not recruiting
      Venezuelan Equine Encephalitis Monovalent Virus-Like Particle Vaccine
      Conditions: Encephalitis; Encephalitis, Viral; Infectious Encephalitis; Virus Diseases; Encephalomyelitis, Venezuelan Equine; Brain Diseases; Central Nervous System Diseases; Central Nervous System Viral Diseases; Alphavirus Infections; Togaviridae Infections; RNA Virus Infections; Central Nervous System Infections; Encephalomyelitis; Physiological Effects of Drugs; Vaccines; Encephalomyelitis, Equine; Nervous System Diseases
    • NCT03110770
      Completed
      VRC 705: A Zika Virus DNA Vaccine in Healthy Adults and Adolescents
      Conditions: Zika Virus; Zika Virus Infection; Virus Diseases; Flavivirus Infections; Flaviviral Diseases; Flaviviridae Infections; RNA Virus Infections
    • NCT00584194
      Completed
      Safety and Immunogenicity Study of Rift Valley Fever Vaccine
      Conditions: Rift Valley Fever
    • NCT03343626
      Completed
      Safety, Immunogenicity and Dose Ranging Study of Inactivated Zika Virus Vaccine in Healthy Adult Participants
      Conditions: Virus, Zika; Zika Virus Disease; Flavivirus Infections; Healthy Participants
    • NCT03679728
      Completed
      Sensorimotor Outcomes of Children Exposed to Foetal Zika Virus Infection
      Conditions: Zika Virus Infection
    • NCT04182685
      Enrolling by invitation
      Evaluation of Medical Conditions Associated With Zika Virus Infection in Managua, Nicaragua
      Conditions: Zika Virus
    • NCT02810210
      Unknown status
      Zika Virus Infection's Neonatal and Pediatric Consequences in French Department of America
      Conditions: Zika Virus Infection on Fetus and Child During the Pregnancy
    • NCT03204409
      Suspended
      ZIKAlliance Natural History Study
      Conditions: Zika Virus; Zika Virus Infection
    • NCT03624946
      Completed
      Study in Healthy Volunteers Evaluating Safety and Pharmacokinetics of Zika Virus Immune Globulin (ZIKV-IG)
      Conditions: Zika Virus Infection; Zika Virus Disease
    • NCT02733796
      Completed
      Persistence of Zika Virus in Semen After Acute Infection
      Conditions: Zika Virus; Zika Virus Disease; Virus Shedding; Transmission
    • NCT03425149
      Completed
      Randomized, Placebo-controlled, Observer-blinded Phase 1 Safety and Immunogenicity Study of Inactivated Zika Virus Vaccine Candidate in Healthy Adults
      Conditions: Zika Virus; Zika Virus Infection
    • NCT03158233
      Completed
      Zika Case Definition and Surveillance Study
      Conditions: Zika Virus Disease
    • NCT00869713
      Active, not recruiting
      Safety and Immunogenicity Study of Rift Valley Fever Vaccine, Inactivated
      Conditions: Rift Valley Fever
    • NCT02996461
      Completed
      VRC 320: A Phase I, Randomized Clinical Trial to Evaluate the Safety and Immunogenicity of a Zika Virus DNA Vaccine, VRC-ZKADNA090-00-VP, Administered Via Needle and Syringe or Needle-free Injector, PharmaJet, inHealthy Adults
      Conditions: Prevention of Zika Infection; Zika-Specific Immune Response
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations